scholarly journals European Multicenter Study for the Evaluation of a Dual-Layer Flow-Diverting Stent for Treatment of Wide-Neck Intracranial Aneurysms: The European Flow-Redirection Intraluminal Device Study

2018 ◽  
Vol 39 (5) ◽  
pp. 841-847 ◽  
Author(s):  
M. Killer-Oberpfalzer ◽  
N. Kocer ◽  
C.J. Griessenauer ◽  
H. Janssen ◽  
T. Engelhorn ◽  
...  
Author(s):  
Markus Dold ◽  
Lucie Bartova ◽  
Gernot Fugger ◽  
Alexander Kautzky ◽  
Marleen M.M. Mitschek ◽  
...  

2014 ◽  
Vol 40 (5) ◽  
pp. 457-471 ◽  
Author(s):  
Susanne Cerwenka ◽  
Timo O. Nieder ◽  
Peggy Cohen-Kettenis ◽  
Griet De Cuypere ◽  
Ira R. Hebold Haraldsen ◽  
...  

Ophthalmology ◽  
2006 ◽  
Vol 113 (4) ◽  
pp. 578-584.e1 ◽  
Author(s):  
Thomas Kohnen ◽  
David Allen ◽  
Catherine Boureau ◽  
Philippe Dublineau ◽  
Christian Hartmann ◽  
...  

1988 ◽  
Vol 19 (2) ◽  
pp. 91-97 ◽  
Author(s):  
J.-M. Lachapelle ◽  
D. P. Bruynzeel ◽  
G. Ducombs ◽  
M. Hannuksela ◽  
J. Ring ◽  
...  

2014 ◽  
Vol 71 (3) ◽  
pp. 1281-1286 ◽  
Author(s):  
Xiang Xu ◽  
Yu Zheng ◽  
Dayong Wang ◽  
Jianzhong Cui ◽  
Xiaoming Shang

2018 ◽  
Vol 11 (5) ◽  
pp. 516-522 ◽  
Author(s):  
Idriss Haffaf ◽  
Frédéric Clarençon ◽  
Eimad Shotar ◽  
Claudia Rolla-Bigliani ◽  
Saskia Vande Perre ◽  
...  

Background and purposeThe Medina embolization device (MED) is a new flow disruption device combining the design of a detachable coil with an intrasaccular flow disrupter. Safety and short-term angiographic effectiveness of this device have recently been reported. However, long-term angiographic results are lacking. We report herein the 18 months’ angiographic outcome in patients treated for a wide-neck intracranial aneurysm with the MED.Materials and methodsNineteen patients (17 female, mean age 50 years) with 20 wide-neck intracranial aneurysms (six ruptured; 14 unruptured) were treated by the MED between January 2015 and June 2016. Procedure-related complications were systematically recorded; discharge and 6–9 months' follow-up modified Rankin Scale scores were assessed. Angiographic mid-term and long-term follow-up were performed with a mean delay of 6.4±1.5 months (n=16 aneurysms) and 17.7±4.2 months (n=15 aneurysms), respectively. Occlusion rates were evaluated after the procedure and at the mid-term and long-term follow-up using the Roy-Raymond scale.ResultsEmbolization with the MED was feasible in all except two cases (2/20, 10%). One per-procedural perforation was recorded (1/20, 5%) and one MED deployment failed because of the aneurysm’s shape (1/20, 5%). Three cases of thromboembolic complications were observed (3/20, 15%). Only one thromboembolic complication was responsible for clinical sequelae. Grade A occlusion rate was 61% (11/18) after the procedure, 75% at 6 months' follow-up (12/16), and 80% (12/15) at long-term follow-up. Two cases (2/18, 11%) of recanalization at mid-term were documented angiographically. No recanalization occurred between the mid-term and long-term follow-up.ConclusionMED is a hybrid embolization device, combining properties of a conventional coil with those of an intrasaccular flow disrupter. Our series focusing on long-term angiographic follow-up shows a satisfactory long-term occlusion rate. Larger series with longer angiographic follow-up times are warranted to confirm these preliminary results.


Sign in / Sign up

Export Citation Format

Share Document